Results 231 to 240 of about 834,867 (353)

The association between PM_2.5 level and respiratory tract infections among children: A cross-sectional study. [PDF]

AIMS Public Health
Krismanuel H, Tjhin P.
europepmc   +1 more source

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial

Clinical Pharmacology &Therapeutics, EarlyView.
Verekitug, a novel, high‐affinity, fully human monoclonal antibody targeting thymic stromal lymphopoietin receptor (TSLPR), is in development as a potential treatment for severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD).
Dave Singh, Chaim M. Brickman, Peter Lloyd, Ashish Kalra, Subhabrata Biswas, Arkadeep Sinha, Alex Mulvanny, Sumathi Sivapalasingam, Oren M. Becker, Aaron Deykin   +9 more
wiley   +1 more source

Epidemiological characteristics of respiratory tract infections caused by Mycoplasma pneumoniae in a hospital in Hangzhou, China: A cross-sectional study. [PDF]

Medicine (Baltimore)
Zeng H, Yan C, Cheng K, Shi L, Fang L, Wu Y.   +5 more
europepmc   +1 more source

The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska natives.

American Journal of Public Health, 2008
T. Hennessy, Troy L Ritter, R. Holman, D. Bruden, K. Yorita, L. Bulkow, J. Cheek, R. Singleton, Jeff Smith   +8 more
semanticscholar   +1 more source

Population Pharmacokinetics of Clesrovimab in Preterm and Full‐Term Infants

Clinical Pharmacology &Therapeutics, EarlyView.
Clesrovimab is a half‐life extended monoclonal antibody targeting the respiratory syncytial virus fusion protein. Three studies (phase Ib/IIa [MK‐1654‐002], phase IIb/III [CLEVER], and phase III [SMART]) were conducted to evaluate the efficacy, safety, and pharmacokinetics (PK) of clesrovimab in infants.
Ziheng Hu, Farina Hellmann, Xiaowei Zang, Nele Plock, Keyur Parmar, Radha A. Railkar, S. Y. Amy Cheung, Brian M. Maas, Ferdous Gheyas   +8 more
wiley   +1 more source

Respiratory tract infections at the Grand Magal de Touba: a seven-year study. [PDF]

Sci Rep
Diouf C, Ouaddane I, Hoang VT, Goumballa N, Ndiaye D, Bassene H, Sambou M, Gautret P, Sokhna C.   +8 more
europepmc   +1 more source

Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy.

Journal of Allergy and Clinical Immunology, 2015
M. Gascon, M. Casas, E. Morales, D. Valvi, A. Ballesteros-Gómez, Noelia Luque, S. Rubio, N. Monfort, R. Ventura, D. Martínez, J. Sunyer, M. Vrijheid   +11 more
semanticscholar   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Frequent respiratory tract infections in children. The role of environmental and genetic factors.

, 2009
Jopje M. Ruskamp
openalex   +1 more source

Viral–bacterial co-infections in the respiratory tract

Current Opinion in Microbiology, 2016
L. Bakaletz
semanticscholar   +1 more source